NovoCure (NVCR)
NovoCure (NVCR) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- NVCR last traded at $10.71 on 2026-11-20, 0.19% for the session.
- NovoCure: market cap $1.25B, revenue $725.39M over the last four quarters.
- Over the past year NVCR returned -6.46%, with a year-to-date return of -17.17%.